Northwire Canada EditionTuesday, July 28, 2026
Sign inSubscribe
Northwire
⌕
MNRG 0.080 −11.1% KFR 1.31 +0.8% AUMN 0.275 +0.0% GLB 0.250 +0.0% BHS 0.045 −10.0% EGR 0.025 +0.0% RIO 2.59 −4.1% GEN 0.070 +0.0% MAI 4.39 −2.0% RYR 0.175 +0.0% SCD 0.170 +1.5% SRC 1.75 −2.8% FOXT 0.155 +0.0% TG 0.180 −2.7% NOBL 0.100 −4.8% MGG 0.300 +0.0% MNRG 0.080 −11.1% KFR 1.31 +0.8% AUMN 0.275 +0.0% GLB 0.250 +0.0% BHS 0.045 −10.0% EGR 0.025 +0.0% RIO 2.59 −4.1% GEN 0.070 +0.0% MAI 4.39 −2.0% RYR 0.175 +0.0% SCD 0.170 +1.5% SRC 1.75 −2.8% FOXT 0.155 +0.0% TG 0.180 −2.7% NOBL 0.100 −4.8% MGG 0.300 +0.0%
Other

Humanoid Global Reports an Update on RideScan's Commercialization Progress

By The Northwire Desk — AI Analysis Oct 07, 2025 · 04:00 ROBO · 0.87 Humanoid Global Holdings Corp.
ROBO · Price

Executive Summary

  • RideScan Ltd. filed a foundational patent application in the UK to protect its AI‑driven risk scoring and anomaly detection technology for robotics.
  • The company is launching pilot deployments with a cohort of 10 partner organizations to demonstrate reduced downtime and enhanced safety across humanoid and industrial robots.
  • RideScan secured £50,000 from an Innovate UK Growth Catalyst grant (execution starting Nov 1 2025) and an additional £40,000 angel investment from a Europe‑based deep‑tech syndicate.

Key Details

  • Patent Filing: Foundational patent application submitted to the United Kingdom Intellectual Property Office covering RideScan’s independent risk scoring and anomaly detection methodology.
  • Pilot Cohort: 10 selected organizations (research institutions and corporate robotics teams) will integrate RideScan’s API to test AI‑driven health checks, downtime reduction, and anomaly identification.
  • Grant Funding: £50,000 awarded by Innovate UK Growth Catalyst Early Stage: New Innovators grant; funds earmarked for commercialization and expansion of core technology, with execution commencing 1 Nov 2025.
  • Angel Investment: Additional £40,000 investment from a Europe‑based deep‑tech angel syndicate that includes research scientists from an AI subsidiary of a Fortune 500 company.
  • Strategic Impact: Humanoid Global’s CEO Shahab Samimi highlighted the progress as strengthening the portfolio’s focus on safe, scalable robotics and positioning RideScan as a cornerstone for trustworthy AI‑driven deployments.

Notable Quotes

“Filing our foundation patent marks a major step in protecting the technology behind that vision, and our upcoming pilots are expected to show how this innovation can help transform the way robots are deployed around the world.” – Dr. Nandakumar, CEO, RideScan

“We believe that this progress not only fortifies our portfolio's focus on safe, scalable robotics but also positions RideScan as a cornerstone in enabling trustworthy AI‑driven deployments worldwide.” – Shahab Samimi, CEO, Humanoid Global Holdings Corp.

Read the original news release →

More from Humanoid Global Holdings Corp.

Jun 24, 2026 · 07:30

Humanoid Global Expands Asia Strategy Through Strategic Partnership with Stellar Bridge Group

M&A / Property Jun 17, 2026 · 07:30

Portfolio company HowToRobot posts record Q1 revenue, but parent stock remains trapped in a steep downtrend near 52-week lows.

Earnings Mar 05, 2026 · 13:25

Humanoid's RideScan forms partnership with Pomo

Production / Operations Mar 05, 2026 · 04:00

Humanoid Global Announces RideScan's Technology Validation and Commercialization Strategy Progression

Production / Operations Feb 26, 2026 · 11:53

Humanoid completes investment in HowToRobot

M&A / Property Feb 26, 2026 · 04:00

Humanoid Global Announces Completion of Strategic Investment and Signed Advisory Agreement with HowToRobot, a Global Marketplace for Robotics Solutions

Other